Theravance Biopharma, Inc. Uncategorized Contracts & Agreements
20 Contracts & Agreements
- Offer Letter with Aziz Sawaf dated June 16, 2014 (Filed With SEC on May 10, 2023)
- Offer Letter with Brett Grimaud dated May 12, 2014 (Filed With SEC on May 10, 2023)
- Audited financial statements of Theravance Respiratory Company, LLC for the year ended December 31, 2021 (Filed With SEC on March 1, 2023)
- Master Consent, dated as of July 13, 2022, by and among Glaxo Group Limited, Theravance Biopharma, Inc. and Royalty Pharma Investments 2019 ICAV (Filed With SEC on July 14, 2022)
- Audited financial statements of Theravance Respiratory Company, LLC for the year ended December 31, 2021 (Filed With SEC on February 28, 2022)
- Offer Letter with Richard Graham August 12, 2015 (Filed With SEC on November 9, 2020)
- Brett K. Haumann Transfer to Theravance Biopharma UK Ltd. Memo (Filed With SEC on May 8, 2020)
- Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 27, 2020)
- Offer Letter with Andrew Hindman dated May 30, 2019 (Filed With SEC on August 5, 2019)
- Memorandum to Brett K. Haumann regarding Transfer to Theravance Biopharma US, Inc., executed April 5, 2018 (Filed With SEC on August 2, 2018)
- Offer Letter with Shehnaaz Suliman dated May 31, 2017 (Filed With SEC on November 8, 2017)
- ACKNOWLEDGEMENT (Filed With SEC on March 11, 2016)
- FIRST AMENDMENT TO RIGHTS AGREEMENT (Filed With SEC on November 10, 2015)
- EXHIBIT A Adjustments to Your Theravance Equity Awards in Connection with the Spin-Off (Filed With SEC on November 12, 2014)
- EXHIBIT A Adjustments to Your Theravance Equity Awards in Connection with the Spin-Off (Filed With SEC on August 14, 2014)
- EXHIBIT A Adjustments to Your Theravance Equity Awards in Connection with the Spin-Off (Filed With SEC on August 14, 2014)
- EXHIBIT A Adjustments to Your Theravance Equity Awards in Connection with the Spin-Off (Filed With SEC on August 14, 2014)
- EXHIBIT A Adjustments to Your Theravance Equity Awards in Connection with the Spin-Off (Filed With SEC on August 14, 2014)
- EMPLOYEE MATTERS AGREEMENT by and between THERAVANCE, INC. and THERAVANCE BIOPHARMA, INC. Dated as of June 1, 2014 (Filed With SEC on June 3, 2014)
- TAX MATTERS AGREEMENT by and between THERAVANCE, INC. and THERAVANCE BIOPHARMA, INC. Dated as of June 2, 2014 (Filed With SEC on June 3, 2014)